InvestSMART

Bio-Gene Technology Ltd (ASX:BGT)

ALERT: Price-sensitive ASX Announcement for BGT
Current share price for BGT : $0.017 -0.006 (-26.09%)+
Announcement
Release
31 Oct 2025 8:17AM
Price at Release
$0.023
Full Release
download
Summary
Bio-Gene Technology Ltd, an Australian agtech company, has reported significant progress in the development and commercialization of its insecticidal products, Flavocide and Qcide, during the first quarter of FY26. The company completed a strategic review of its product pipeline and identified additional applications for its products. Significant funding was raised through a recent Placement and Share Purchase Plan, amounting to A$2.46 million. Bio-Gene is also advancing its regulatory submission process, with promising efficacy results for Flavocide against ticks presented at a major conference. The company also initiated programs funded by the US Department of Defense and continues to engage with potential commercial partners globally.
Key Points
  • Bio-Gene Technology Ltd focused on Flavocide and Qcide development.
  • Flavocide showed more than 90% mortality against Ixodes scapularis ticks.
  • Qcide's 14th harvest was completed with optimized yield.
  • US Department of Defense funding for Flavocide and Qcide programs.
  • A$2.46m raised through Placement and Share Purchase Plan.
  • Strategic partnerships and product applications continue to expand.
  • Estimated 0.98 quarters of funding available based on current cash flow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.